Related Experiment Video

Updated: May 27, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

BCR-ABL mutations in chronic myeloid leukemia

Thomas Ernst1, Paul La Rosée, Martin C Müller

  • 1Klinik für Innere Medizin II, Universitätsklinikum Jena, Erlanger Allee 101, 07740 Jena, Germany.

Hematology/Oncology Clinics of North America
|November 8, 2011
PubMed

Insights

Imatinib resistance in chronic myeloid leukemia (CML) is often due to BCR-ABL mutations. Early detection of these mutations can guide treatment decisions for CML patients.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Imatinib revolutionized chronic myeloid leukemia (CML) treatment.
  • However, some CML patients develop resistance or relapse during imatinib therapy.

Purpose of the Study:

  • To investigate the role of BCR-ABL mutations in imatinib resistance.
  • To understand the impact of these mutations on kinase activity and treatment outcomes.

Main Methods:

  • Analysis of BCR-ABL kinase domain mutations in imatinib-resistant CML patients.
  • Identification of frequently mutated residues associated with resistance.

Main Results:

  • Over 100 BCR-ABL point mutations identified in resistant CML patients.
  • Seven specific mutations account for two-thirds of all detected mutations.
  • Mutations alter imatinib binding or regulatory regions, reducing sensitivity while maintaining kinase activity.

Conclusions:

  • BCR-ABL mutations are a key mechanism of imatinib resistance in CML.
  • Early detection of BCR-ABL mutants can aid in risk stratification.
  • Identifying specific mutations may inform personalized treatment strategies for CML.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Concept Videos

Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...